We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+5.99%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$63.9B
AUM Growth
+$3.43B
(+5.7%)
Cap. Flow
+$105M
Cap. Flow
% of AUM
0.16%
Top 10 Holdings %
Top 10 Hldgs %
21.18%
Holding
4,866
New
886
Increased
1,406
Reduced
1,667
Closed
823
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3B |
| 2 |
Microsoft
MSFT
|
+$508M |
| 3 |
State Street Real Estate Select Sector SPDR ETF
XLRE
|
+$209M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$190M |
| 5 |
Qualcomm
QCOM
|
+$167M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$711M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$184M |
| 3 |
Oracle
ORCL
|
+$168M |
| 4 |
Gilead Sciences
GILD
|
+$140M |
| 5 |
Snowflake
SNOW
|
+$137M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.98% |
| 2 | Consumer Discretionary | 6.34% |
| 3 | Financials | 4.35% |
| 4 | Healthcare | 4.2% |
| 5 | Industrials | 3.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3676
PUT
Riot Platforms
RIOT
$8.52B
| $202K | ﹤0.01% |
27,200
-68,100
| -71% | -$590K |
|
3677
Mativ Holdings
MATV
$448M
| $202K | ﹤0.01% |
+11,877
| New | +$209K |
|
3678
iShares MSCI France ETF
EWQ
$324M
| $201K | ﹤0.01% |
+4,983
| New | +$194K |
|
3679
ProShares Ultra Dow30
DDM
$531M
| $201K | ﹤0.01% |
4,200
-1,078
| -20% | -$47.8K |
|
3680
CALL
Novavax
NVAX
$1.23B
| $200K | ﹤0.01% |
+15,800
| New | +$204K |
|
3681
Clarus
CLAR
$125M
| $199K | ﹤0.01% |
+44,198
| New | +$223K |
|
|
FRGE
3682
DELISTED
Forge Global Holdings
FRGE
| $197K | ﹤0.01% |
10,024
-940
| -9% | -$19.6K |
|
3683
CALL
Portillo's
PTLO
$315M
| $197K | ﹤0.01% |
+14,600
| New | +$163K |
|
|
DEA
3684
Easterly Government Properties
DEA
$1.18B
| $197K | ﹤0.01% |
+5,789
| New | +$194K |
|
3685
Ocular Therapeutix
OCUL
$1.86B
| $196K | ﹤0.01% |
22,478
-42,433
| -65% | -$350K |
|
3686
CALL
3D Systems Corp
DDD
$420M
| $193K | ﹤0.01% |
68,100
-247,100
| -78% | -$711K |
|
3687
Health Catalyst
HCAT
$154M
| $193K | ﹤0.01% |
23,708
-71,755
| -75% | -$519K |
|
|
PGRE
3688
DELISTED
Paramount Group
PGRE
| $193K | ﹤0.01% |
+39,190
| New | +$194K |
|
|
CRON
3689
CALL
Cronos Group
CRON
$1.05B
| $192K | ﹤0.01% |
87,600
-209,900
| -71% | -$480K |
|
3690
Olema Pharmaceuticals
OLMA
$1.02B
| $191K | ﹤0.01% |
15,969
-41,101
| -72% | -$525K |
|
3691
Vera Bradley
VRA
$105M
| $190K | ﹤0.01% |
+34,890
| New | +$206K |
|
|
VLRS
3692
Controladora Vuela Compania de Aviacion
VLRS
$876M
| $190K | ﹤0.01% |
30,019
-30,690
| -51% | -$187K |
|
3693
Myers Industries
MYE
$1.18B
| $190K | ﹤0.01% |
+13,738
| New | +$194K |
|
3694
Forrester Research
FORR
$172M
| $190K | ﹤0.01% |
10,526
-17,780
| -63% | -$324K |
|
3695
Taboola.com
TBLA
$1.32B
| $189K | ﹤0.01% |
56,238
-67,713
| -55% | -$223K |
|
3696
Coeur Mining
CDE
$15.6B
| $189K | ﹤0.01% |
27,411
-211,578
| -89% | -$1.32M |
|
3697
Omeros
OMER
$709M
| $188K | ﹤0.01% |
+47,364
| New | +$202K |
|
3698
Embecta
EMBC
$195M
| $187K | ﹤0.01% |
13,293
-15,469
| -54% | -$225K |
|
3699
Lyell Immunopharma
LYEL
$309M
| $187K | ﹤0.01% |
+6,775
| New | +$199K |
|
3700
Savara
SVRA
$1.13B
| $187K | ﹤0.01% |
44,095
-68,143
| -61% | -$301K |
|
Similar funds
Squarepoint's Q3 2024 Portfolio in Review
As of Q3 2024, Squarepoint held 4,866 positions worth $63.9B, up 5.7% from $60.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Squarepoint's Q3 2024 filing shows 886 new, 1,406 increased, 1,667 reduced and 823 closed positions. Its largest new stake was State Street Real Estate Select Sector SPDR ETF: 4,950,000 shares worth $221M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $711M.
By sector, the portfolio is most concentrated in Technology at 9% of assets, down from 9.1% a quarter earlier, followed by Consumer Discretionary and Financials.
- Squarepoint's largest Q3 2024 buy was State Street Real Estate Select Sector SPDR ETF: 4,950,000 shares worth $221M.
- Squarepoint added most to iShares Core S&P 500 ETF in Q3 2024, an estimated $3B increase.
- Squarepoint's biggest Q3 2024 reduction was Bristol-Myers Squibb, cutting an estimated $184M.
- Squarepoint fully exited State Street SPDR S&P 500 ETF Trust in Q3 2024, selling an estimated $711M.
- Squarepoint's ten largest holdings make up 21% of its $63.9B portfolio in Q3 2024.
- Squarepoint opened 886 new positions and closed 823 in Q3 2024.
- Squarepoint's portfolio value rose 5.7% quarter-over-quarter to $63.9B.
Based on Squarepoint's 13F filing for Q3 2024, filed 14 Nov 2024.